Completed PHASE4 INTERVENTIONAL 2-arm NCT01327391

Tolerance of on Line Hemodiafiltration in Chronic Renal Failure Patients (on-line-HDF)

Tolerance of on Line Hemodiafiltration and Impact on Morbidity and Cardiovascular Risk Factors in Chronic Renal Failure Patients

Sponsor: Ministry of Health, France

Conditions Cardiovascular Disease

Interventions Hemodialysis On line Hemodiafiltration

Updated 5 times since 2017 Last updated: Dec 5, 2014 Started: May 31, 2005 Primary completion: May 31, 2013 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01327391, this PHASE4 trial focuses on Cardiovascular Disease and remains completed. Sponsored by Ministry of Health, France, it has been updated 5 times since 2005, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ministry of Health, France
University Hospital, Montpellier

Data source: University Hospital, Montpellier

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montpellier, France